CBIS Cannabis Science Sets Second FDA Drug Target on $20 Billion "Chronic Pain" Market Targeting the Huge Need for Safe Non-Addictive Non-Lethal Cannabis Based Medications
By Staff
COLORADO SPRINGS, Colo., Mar 4, 2010 (GlobeNewswire via COMTEX) --
Cannabis Science, Inc. (OTCBB:CBIS)
In the world of pennies, there is no black or white, just red and GREEN.
These opinions and thoughts are mine, you are on your own .